Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether 4 weeks of dosing with senicapoc alleviates exercise induced asthma symptoms.

Phase 2

Icagen